Related references
Note: Only part of the references are listed.SV40 and human mesothelioma
Michele Carbone et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Detection and genotyping of CMV and HPV in tumors and fallopian tubes from epithelial ovarian cancer patients
Edyta Paradowska et al.
SCIENTIFIC REPORTS (2019)
Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells
Quirin Hammer et al.
NATURE IMMUNOLOGY (2018)
Cytomegalovirus Viral Load in Bronchoalveolar Lavage to Diagnose Lung Transplant Associated CMV Pneumonia
Isabelle Paula Lodding et al.
TRANSPLANTATION (2018)
Cytomegalovirus establishes a latent reservoir and triggers long-lasting inflammation in the eye
Valentina Voigt et al.
PLOS PATHOGENS (2018)
CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors
Qingda Meng et al.
SCIENTIFIC REPORTS (2018)
Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia
Elena Beam et al.
CLINICAL TRANSPLANTATION (2018)
Cytomegalovirus (CMV) DNA Quantitation in Bronchoalveolar Lavage Fluid From Hematopoietic Stem Cell Transplant Recipients With CMV Pneumonia
Michael Boeckh et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Association Between Cytomegalovirus Reactivation and Clinical Outcomes in Immunocompetent Critically Ill Patients: A Systematic Review and Meta-Analysis
Philippe Lachance et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Human cytomegalovirus escapes immune recognition by NK cells through the downregulation of B7-H6 by the viral genes US18 and US20
Yoav Charpak-Amikam et al.
SCIENTIFIC REPORTS (2017)
CMV viral load in bronchoalveolar lavage for diagnosis of pneumonia in allogeneic hematopoietic stem cell transplantation
L. Iglesias et al.
BONE MARROW TRANSPLANTATION (2017)
Infections in Cancer Patients with Solid Tumors: A Review
Kenneth V. I. Rolston
INFECTIOUS DISEASES AND THERAPY (2017)
Cytomegalovirus reactivation in ICU patients
Laurent Papazian et al.
INTENSIVE CARE MEDICINE (2016)
Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vector
Michael Quinn et al.
IMMUNOTHERAPY (2016)
638. Development of Dual Targeted Oncolytic Adenovirus for Human Malignant Mesothelioma
MOLECULAR THERAPY (2016)
Cytomegalovirus and glioblastoma; controversies and opportunities
Sean E. Lawler
JOURNAL OF NEURO-ONCOLOGY (2015)
How understanding immunology contributes to managing CMV disease in immunosuppressed patients: now and in future
J. G. Patrick Sissons et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2015)
Cytomegalovirus reactivation and its clinical impact in patients with solid tumors
Konstantin Schlick et al.
INFECTIOUS AGENTS AND CANCER (2015)
Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients
Emanuela Taioli et al.
PLOS ONE (2015)
Cytomegalovirus pneumonia as the first manifestation of severe combined immunodeficiency
Aleksandra Szczawinska-Poplonyk et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activation
Charles Cobbs et al.
ONCOTARGET (2014)
Clinical Utility of Viral Load in Management of Cytomegalovirus Infection after Solid Organ Transplantation
Raymund R. Razonable et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
Prognosis and prognostic factors of patients with mesothelioma: a population-based study
S. van der Bij et al.
BRITISH JOURNAL OF CANCER (2012)
The relationship between tumor MSLN methylation and serum mesothelin (SMRP) in mesothelioma
Heather H. Nelson et al.
EPIGENETICS (2011)
Risk factors and outcomes of cytomegalovirus viremia in cancer patients: A study from a medical center in northern Taiwan
Yung-Chih Wang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2011)
Oncomodulation by human cytomegalovirus: novel clinical findings open new roads
Martin Michaelis et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2011)
Cytomegalovirus Seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988-2004
Sheri Lewis Bate et al.
CLINICAL INFECTIOUS DISEASES (2010)
Cytomegalovirus Viruria and DNAemia in Healthy Seropositive Women
Nitin Arora et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
CMV Pneumonia in HIV-Infected Ventilated Infants
P. Goussard et al.
PEDIATRIC PULMONOLOGY (2010)
Analytic Review: Viral Pneumonias in Immunocompromised Adult Hosts
Karen Joan Vigil et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2010)
Epigenetic Profiles Distinguish Pleural Mesothelioma from Normal Pleura and Predict Lung Asbestos Burden and Clinical Outcome
Brock C. Christensen et al.
CANCER RESEARCH (2009)
Cytomegalovirus infection in critically ill patients: a systematic review
Ryosuke Osawa et al.
CRITICAL CARE (2009)
Cytomegalovirus strain diversity in seropositive women
Zdenek Novak et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation
F Cinatl et al.
MEDICINAL RESEARCH REVIEWS (2005)
Susceptibility of mesothelioma cell lines to adeno-associated virus 2 vector-based suicide gene therapy
S Berlinghoff et al.
LUNG CANCER (2004)
Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology
J Cinati et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2
T Compton et al.
JOURNAL OF VIROLOGY (2003)
Human cytomegalovirus infections in nonimmunosuppressed critically ill patients
A Heininger et al.
CRITICAL CARE MEDICINE (2001)
Share Paper
